More than 80% of patients in this clinical trial rated Journavx as a good, very good or excellent pain medication when investigating multiple acute pain types. The new drug "offers a safer option ...

A recent study shows that the lack of trust is justified. Your doctor may be ignoring your pain. Here’s what you need to know ...

With this approval, Vertex becomes the first pharmaceutical company in 25 years to introduce a new class of pain medication in ... option could offer hope for patients and healthcare providers ...

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment ...